IDXX

415.87

1.58% -6.67

Dopo l'orario di chiusura: 415.87

Idexx Laboratories Inc (IDXX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IDXX Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$422.54

Aprire:

$422.54

Volume 24 ore:

470.12K

Relative Volume:

0.73

Capitalizzazione di mercato:

$34.36B

Reddito:

$3.90B

Utile/perdita netta:

$887.87M

Rapporto P/E:

38.98

EPS:

10.67

Flusso di cassa netto:

$798.08M

1 W Prestazione:

-1.22%

1M Prestazione:

-5.70%

6M Prestazione:

-18.74%

1 anno Prestazione:

-22.98%

Intervallo 1D:

$415.21

$423.81

Intervallo di 1 settimana:

$414.39

$430.15

Portata 52W:

$398.50

$548.88

Idexx Laboratories Inc Stock (IDXX) Company Profile

Nome

Idexx Laboratories Inc

Settore

Healthcare (1166)

Industria

Diagnostics & Research (59)

Telefono

(207) 556-0300

Indirizzo

ONE IDEXX DRIVE, WESTBROOK, ME

Dipendente

Cinguettio

@idexx

Prossima data di guadagno

2025-02-03

Ultimi documenti SEC

IDXX's Discussions on Twitter

Confronta IDXX con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IDXX Idexx Laboratories Inc	415.87	34.36B	3.90B	887.87M	798.08M	10.67
TMO Thermo Fisher Scientific Inc	500.16	196.14B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	205.85	150.17B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	116.69	33.28B	6.53B	1.26B	1.31B	4.35
IQV Iqvia Holdings Inc	177.39	31.62B	15.41B	1.37B	2.11B	7.50

Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-12-02	Iniziato	Leerink Partners	Outperform
2024-07-25	Iniziato	BTIG Research	Buy
2024-01-30	Downgrade	Piper Sandler	Overweight → Neutral
2023-12-07	Iniziato	Exane BNP Paribas	Outperform
2023-12-04	Aggiornamento	Cleveland Research	Neutral → Buy
2023-08-02	Downgrade	Atlantic Equities	Overweight → Neutral
2022-07-25	Downgrade	Stifel	Buy → Hold
2022-07-21	Aggiornamento	Goldman	Neutral → Buy
2022-07-12	Iniziato	Piper Sandler	Overweight
2022-05-05	Downgrade	BofA Securities	Buy → Neutral
2022-02-08	Iniziato	Atlantic Equities	Overweight
2021-11-18	Iniziato	Morgan Stanley	Overweight
2021-08-05	Ripresa	Credit Suisse	Outperform
2021-07-12	Downgrade	Guggenheim	Buy → Neutral
2021-02-17	Iniziato	Barclays	Overweight
2019-09-09	Iniziato	Goldman	Neutral
2019-05-23	Iniziato	Guggenheim	Buy
2018-11-02	Reiterato	BofA/Merrill	Buy
2018-05-07	Reiterato	Stifel	Buy
2018-01-16	Iniziato	Piper Jaffray	Overweight
2017-08-23	Aggiornamento	BofA/Merrill	Neutral → Buy
2017-07-28	Aggiornamento	CL King	Neutral → Buy
2017-02-03	Downgrade	Feltl & Co.	Hold → Sell
2016-09-29	Ripresa	BofA/Merrill	Neutral
2016-08-16	Reiterato	Stifel	Buy
2016-08-03	Aggiornamento	Northcoast	Sell → Neutral
2016-07-20	Reiterato	Canaccord Genuity	Buy
2016-04-19	Reiterato	Canaccord Genuity	Buy
2016-04-01	Iniziato	CL King	Neutral
2016-03-21	Reiterato	Stifel	Buy
2016-02-04	Iniziato	Credit Suisse	Outperform
2015-10-29	Reiterato	Stifel	Buy
2015-08-28	Downgrade	Raymond James	Outperform → Mkt Perform
2015-08-13	Reiterato	Stifel	Buy
2015-07-23	Reiterato	Canaccord Genuity	Buy

Mostra tutto

Idexx Laboratories Inc Borsa (IDXX) Ultime notizie

Mar 30, 2025

We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease - Simply Wall St

Mar 30, 2025

Mar 29, 2025

Meet the Little-Known S&P 500 Stock That Has Rocketed 10,230% Higher Since 2000 - Yahoo Finance

Mar 29, 2025

Mar 28, 2025

Form DEF 14A IDEXX LABORATORIES INC For: Dec 31 - StreetInsider.com

Mar 28, 2025

6,931 Shares in IDEXX Laboratories, Inc. (NASDAQ:IDXX) Acquired by Howe & Rusling Inc. - MarketBeat

Mar 28, 2025

Mar 26, 2025

Is IDEXX Laboratories, Inc. (IDXX) The Best Pet Stock to Buy According to Billionaires? - Insider Monkey

Mar 26, 2025

8 Best Pet Stocks to Buy According to Billionaires - Insider Monkey

Mar 26, 2025

Mar 24, 2025

Why IDEXX Laboratories, Inc. (IDXX) is Among the Best Diagnostics Stocks to Invest in Right Now - Insider Monkey

Mar 24, 2025

IDEXX Laboratories Insiders Sell US$1.9m Of Stock, Possibly Signalling Caution - Yahoo Finance

Mar 24, 2025

Mar 23, 2025

12 Best Diagnostics Stocks to Invest In Right Now - Insider Monkey

Mar 23, 2025

Mar 18, 2025

Idexx's Economic Moat Remains Solid, but Softer Consumer Confidence Could Weigh on Near Term - Morningstar

Mar 18, 2025

Should You Retain IDEXX Stock in Your Portfolio for Now? - TradingView

Mar 18, 2025

Mar 17, 2025

IDEXX Laboratories: Cancer Dx Launch In March 2025; Upgrading To ‘Buy’ (NASDAQ:IDXX) - Seeking Alpha

Mar 17, 2025

Mar 14, 2025

Is IDEXX Laboratories Stock Underperforming the Nasdaq? - Nasdaq

Mar 14, 2025

The total return for IDEXX Laboratories (NASDAQ:IDXX) investors has risen faster than earnings growth over the last five years - Simply Wall St

Mar 14, 2025

Is IDEXX Laboratories Stock Underperforming The Nasdaq? - Barchart

Mar 14, 2025

Mar 13, 2025

Jones Financial Companies Lllp Sells 194 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - Defense World

Mar 13, 2025

Mar 12, 2025